news

Arvato Systems signs deal with SecurMed UK to deliver medicines verification

SecurMed UK, the UK Medicines Verification Organisation, is entering into a Letter of Intent with Arvato Systems as its IT blueprint service provider.

SecurMed UK, the UK Medicines Verification Organisation, is entering into a Letter of Intent with Arvato Systems as its IT blueprint service provider.

In a joint statement, SecurMed UK and Arvato Systems said they were looking forward to “working together to enable the UK medicines supply and healthcare sectors to successfully implement the UK Medicines Verification System by 9 February 2019”.

​​​The UK is one of the largest and most complex markets for medicines supply within Europe and the appointment of Arvato Systems represents a significant milestone in the UK’s journey to meet its obligations under the Falsified Medicines Directive and associated Delegated Regulation, according to the statement.

SecurMed UK is the not-for profit organisation that will manage the UK Medicines Verification System under the supervision of the UK national competent authorities – MHRA and Department of Health. SecurMed UK has been incorporated by the principal supply chain stakeholder associations (Association of British Pharmaceutical Industry (ABPI), British Generic Manufacturers Association (BGMA), British Association of European Pharmaceutical Distributors (BAEPD), Healthcare Distribution Association (HDA), National Pharmacy Association (NPA) and Company Chemists’ Association (CCA)) as required by the Falsified Medicines Directive.

Global IT specialist Arvato Systems supports major companies through digital transformation. It develops innovative IT solutions, transitions its clients into the Cloud, integrates digital processes and take on IT systems operation and support.​ In Healthcare, Arvato Systems provides its own serialisation solutions covering the entire end-to-end process chain that support both individual producers and national verification systems. It was chosen as an official service provider by the European Medicines Verification Organization (EMVO). 

Send this to a friend